Fundraising Fox
/Companies
Sign in

Sancilio

Riviera Beach, US · 1 known investors

Find your way into Sancilio

Sign up to see every warm intro you have to Sancilio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sancilio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Sancilio & Company provides guidance and regulatory support to early-stage biopharmaceutical entrepreneurs on compliance, manufacturing, and funding strategy. Through its subsidiary Clearway Global, the firm offers a network of FDA-regulated services including drug manufacturing, formulation development, clinical trials, and regulatory submissions.

Biotech

Founders & leadership

FSFrederick Sancilio
Frederick SancilioFounderFrederick Sancilio is Principal Owner and Operating Partner of Sancilio & Company, Inc., which provides regulatory guidance and manufacturing support to early-stage biopharmaceutical companies, and President of its consulting subsidiary Clearway Global. He has founded multiple healthcare companies including aaiPharma (now Alcami), Aesgen, and Endeavor Pharmaceuticals, held CEO and board positions at public and private biopharmaceutical firms, and serves as Research Professor at Florida Atlantic University.
DG
Daren GrahamExecutive
AF
Andrew FolmerExecutive
SP
Stephen PorterExecutive

Board

DL
Dennis LangerBoard director
PG
Patrick GrayBoard director
AD
Alan DuntonBoard director
RJ
Roderick JacksonBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$22M disclosed across 2 rounds · 2012–2014

▶$20MraisedJul 2014 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Roderick JacksonDirector
  • Dennis LangerDirector
  • C. Chad HarrellExecutive Officer
  • Ted StoverExecutive Officer
  • Alan DuntonDirector
  • Frederick SancilioExecutive Officer, Director
  • Martin ZeigerDirector
  • Patrick GrayDirector
  • Kelly PerkinsDirector
  • Thorsteinsson ThorsteinnExecutive Officer
  • Carla CoxExecutive Officer
Offering amount
$20M
Amount sold
$20M
Minimum investment
$1
Sales commissions
$1M
Placement agents
Noble Financial Capital Markets
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2012 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis LangerDirector
  • Daren GrahamExecutive Officer
  • Frederick SancilioExecutive Officer, Director
  • Andrew FolmerExecutive Officer
  • Patrick GrayDirector
  • Alan DuntonDirector
  • Stephen PorterExecutive Officer
  • Roderick JacksonDirector
Offering amount
$4M
Amount sold
$2M
Minimum investment
$1
Proceeds to insiders
$50K
First sale
Feb 2012
Incorporated
Corporation, Florida
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Sancilio do?
Sancilio & Company provides guidance and regulatory support to early-stage biopharmaceutical entrepreneurs on compliance, manufacturing, and funding strategy. Through its subsidiary Clearway Global, the firm offers a network of FDA-regulated services including drug manufacturing, formulation development, clinical trials, and regulatory submissions.
Who founded Sancilio?
Sancilio was founded by Frederick Sancilio.
Who are Sancilio's investors?
Sancilio's investors include Signet Healthcare Partners.
How much funding has Sancilio raised?
Sancilio has disclosed $22M raised across 2 rounds.
Where is Sancilio headquartered?
Sancilio is headquartered in Riviera Beach, US.